共 118 条
[1]
Haller JA(2011)For the Ozurdex GENEVA Study Group Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal vein Occlusion Ophthalmology 118 2453-60
[2]
Bandello F(2011)Pharmacokinetics and pharmacodynamics of a sustained- release dexamethasone intravitreal implant Invest Ophthalmol Vis Sci 52 80-6
[3]
Belfort R(2014)Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1) Eye 28 318-26
[4]
Blumenkranz MS(2012)Rebound effect after intravitreal dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion J Ocul Pharmacol Ther 28 566-8
[5]
Gillies M(1982)New visual acuity charts for clinical research Am J Ophthalmol 94 91-96
[6]
Heier J(2013)Microperimetry and clinical practive: an evidence- based review Can J Ophthalmol 48 350-7
[7]
Loewenstein A(2012)Microperimetry as a routine diagnostic test in the follow- up of retinal vein occlusion? Graefes Arch Clin Exp Ophthalmol 250 175-83
[8]
Hee Yoon Y(2009)Confidence interval or p-value?: part 4 of a series on evaluation of scientific publications Dtsch Aerztebl Int 106 335-9
[9]
Jiao J(2009)Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year Ophthalmology 116 2415-21
[10]
Chang Lin JE(2013)Response of retinal sensitivity to ranibizumab treatment of macular edema after acute branch retinal vein occlusion Retina 33 1220-6